ExLibris header image
SFX Logo
Title: Membrane potential shapes regulation of dopamine transporter trafficking at the plasma membrane
Source:

Nature Communications [2041-1723] yr:2016


Collapse list of basic services Basic
Full text
Full text available via Nature
GO
Full text available via PubMed Central
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Solly, K. "High-Throughput Screen of GluK1 Receptor Identifies Selective Inhibitors with a Variety of Kinetic Profiles Using Fluorescence and Electrophysiology Assays." Journal of biomolecular screening 20.6 (2015): 708-719. Link to Full Text for this item Link to SFX for this item
2. Brooks, David J. "Molecular Imaging of Dopamine Transporters." Ageing research reviews 30 (2016): 114-121. Link to SFX for this item
3. Gabriel, Luke R. "Dopamine transporter endocytic trafficking in striatal dopaminergic neurons: Differential dependence on dynamin and the actin cytoskeleton." The Journal of neuroscience 33.45 (2013): 17836-17846. Link to Full Text for this item Link to SFX for this item
4. Ge, S. "Cadmium induces actin cytoskeleton alterations and dysfunction in Neuro-2a cells." Environmental Toxicology 34.4 (2019): 469-475. Link to Full Text for this item Link to SFX for this item
5. Wyman Chick, Kathryn A. "Cognition in Patients With a Clinical Diagnosis of Parkinson Disease and Scans Without Evidence of Dopaminergic Deficit (SWEDD)." Cognitive and behavioral neurology 29.4 (2016): 190-196. Link to SFX for this item
6. Zou, J. "Position Emission Tomography/Single-Photon Emission Tomography Neuroimaging for Detection of Premotor Parkinson's Disease." CNS neuroscience & therapeutics 22.3 (2016): 167-177. Link to Full Text for this item Link to SFX for this item
7. Rizzo, G. "Accuracy of clinical diagnosis of Parkinson disease: A systematic review and meta-analysis." Neurology 86.6 (2016): 566-576. Link to SFX for this item
8. Buddhala, C. "Dopaminergic, serotonergic, and noradrenergic deficits in Parkinson disease." Annals of Clinical and Translational Neurology 2.10 (2015): 949-59. Link to Full Text for this item Link to SFX for this item
9. Yao, S. "Genetically encoding a light switch in an ionotropic glutamate receptor reveals subunit-specific interfaces." Proceedings of the National Academy of Sciences of the United States of America 111.16 (2014): 6081-6086. Link to Full Text for this item Link to SFX for this item
10. Kenakin, T. "Signalling bias in new drug discovery: detection, quantification and therapeutic impact." Nature reviews. Drug discovery 12.3 (2012): 205-16. Link to SFX for this item
11. PG, B. "Dystonic tremor presenting as parkinsonism: long-term follow-up of SWEDDs." Neurology 72.16 (2009): 1443-1445. Link to SFX for this item
12. Schafer, D. "Disruption of the Axon Initial Segment Cytoskeleton Is a New Mechanism for Neuronal Injury." The journal of neuroscience 29.42 (2009): 13242-13254. Link to Full Text for this item Link to SFX for this item
13. Leff, P. "Estimation of partial agonist affinity by interaction with a full agonist: a direct operational model-fitting approach." British journal of pharmacology 110.1 (1993): 239-44. Link to Full Text for this item Link to SFX for this item
14. MartÃ, Maria J. "Parkinson disease: New guidelines for diagnosis of Parkinson disease." Nature reviews. Neurology 9.4 (2013): 190-191. Link to SFX for this item
15. Rajagopal, S. "Teaching old receptors new tricks: biasing seven-transmembrane receptors." Nature Reviews. Drug Discovery 9.5 (2010): 373-386. Link to SFX for this item
16. Zernig, H. "Signal transduction efficacy of the highly potent mu opioid agonist 14-methoxymetopon." Life Sciences (2000): 1871-7. Link to Full Text for this item Link to SFX for this item
17. "Premotor Diagnosis of Parkinson's Disease." Neuroscience Bulletin 33.5: 526-534. Link to SFX for this item
18. Zhu, S. "Mechanism of NMDA Receptor Inhibition and Activation." Cell 165.3 (2016): 704-714. Link to SFX for this item
19. Monchi, O. "Markers of cognitive decline in PD: The case for heterogeneity." Parkinsonism & related disorders 24 (2016): 8-14. Link to SFX for this item
20. Müller, T. "Laboratory assessments in the course of Parkinson's disease: a clinician's perspective." Journal of Neural Transmission 123.1 (2016): 65-71. Link to Full Text for this item Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced
A service provided by the Library of the Wissenschaftspark Albert Einstein, Potsdam, Germany.
© 2005 SFX by Ex Libris Inc.